In this short interview, Dr James Gammie (University of Maryland Medical Center, MD, US) discusses the findings from surgical trial assessing the benefit of concomitant tricuspid repair during mitral valve surgery. The trial, presented at AHA 2021, demonstrated that at 2 years, TA had no impact on MACCE, survival, or QOL.
1. Reasoning for this Study
2. Study Design and Patient Population
3. Key Findings
4. Take-home Messages
5. Next Steps
Recorded remotely from Baltimore, 2021.
Editor: Mirjam Boros